
Company Number
SC468250
Next Accounts
Oct 2025
Shareholders
callum beveridge
grant beveridge
View AllGroup Structure
View All
Industry
Management consultancy activities (other than financial management)
Registered Address
8 mitchell street, leven, fife, KY8 4HJ
Website
-Pomanda estimates the enterprise value of SYMPA MEDICAL LTD at £97.3k based on a Turnover of £275.1k and 0.35x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SYMPA MEDICAL LTD at £295.7k based on an EBITDA of £97.1k and a 3.05x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SYMPA MEDICAL LTD at £334.3k based on Net Assets of £128.1k and 2.61x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Sympa Medical Ltd is a live company located in fife, KY8 4HJ with a Companies House number of SC468250. It operates in the management consultancy activities other than financial management sector, SIC Code 70229. Founded in January 2014, it's largest shareholder is callum beveridge with a 30% stake. Sympa Medical Ltd is a established, micro sized company, Pomanda has estimated its turnover at £275.1k with high growth in recent years.
Pomanda's financial health check has awarded Sympa Medical Ltd a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
4 Weak
Size
annual sales of £275.1k, make it smaller than the average company (£408.7k)
- Sympa Medical Ltd
£408.7k - Industry AVG
Growth
3 year (CAGR) sales growth of 26%, show it is growing at a faster rate (9.7%)
- Sympa Medical Ltd
9.7% - Industry AVG
Production
with a gross margin of 26.2%, this company has a higher cost of product (60.6%)
- Sympa Medical Ltd
60.6% - Industry AVG
Profitability
an operating margin of 35.3% make it more profitable than the average company (8.4%)
- Sympa Medical Ltd
8.4% - Industry AVG
Employees
with 2 employees, this is below the industry average (4)
2 - Sympa Medical Ltd
4 - Industry AVG
Pay Structure
on an average salary of £49.9k, the company has an equivalent pay structure (£49.9k)
- Sympa Medical Ltd
£49.9k - Industry AVG
Efficiency
resulting in sales per employee of £137.6k, this is equally as efficient (£120.4k)
- Sympa Medical Ltd
£120.4k - Industry AVG
Debtor Days
it gets paid by customers after 203 days, this is later than average (65 days)
- Sympa Medical Ltd
65 days - Industry AVG
Creditor Days
its suppliers are paid after 46 days, this is slower than average (25 days)
- Sympa Medical Ltd
25 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Sympa Medical Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Sympa Medical Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 17.2%, this is a lower level of debt than the average (53.9%)
17.2% - Sympa Medical Ltd
53.9% - Industry AVG
Sympa Medical Ltd's latest turnover from January 2024 is estimated at £275.1 thousand and the company has net assets of £128.1 thousand. According to their latest financial statements, Sympa Medical Ltd has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||
Other Income Or Grants | ||||||||||
Cost Of Sales | ||||||||||
Gross Profit | ||||||||||
Admin Expenses | ||||||||||
Operating Profit | ||||||||||
Interest Payable | ||||||||||
Interest Receivable | ||||||||||
Pre-Tax Profit | ||||||||||
Tax | ||||||||||
Profit After Tax | ||||||||||
Dividends Paid | ||||||||||
Retained Profit | ||||||||||
Employee Costs | ||||||||||
Number Of Employees | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 2 | |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 1,253 | 398 | 795 | 421 | 846 | 244 | 866 | 1,268 | 1,018 | |
Intangible Assets | ||||||||||
Investments & Other | ||||||||||
Debtors (Due After 1 year) | ||||||||||
Total Fixed Assets | 1,253 | 398 | 795 | 421 | 846 | 244 | 866 | 1,268 | 1,018 | |
Stock & work in progress | ||||||||||
Trade Debtors | 153,341 | 70,128 | 75,189 | 76,166 | 84,521 | 12,525 | 13,691 | 33,043 | 13,682 | 15,939 |
Group Debtors | ||||||||||
Misc Debtors | 115 | 115 | 115 | |||||||
Cash | 40,042 | 39,844 | 47,224 | 102,579 | 107,611 | |||||
misc current assets | ||||||||||
total current assets | 153,456 | 70,243 | 75,304 | 76,166 | 84,521 | 52,567 | 53,535 | 80,267 | 116,261 | 123,550 |
total assets | 154,709 | 70,641 | 76,099 | 76,166 | 84,942 | 53,413 | 53,779 | 81,133 | 117,529 | 124,568 |
Bank overdraft | ||||||||||
Bank loan | ||||||||||
Trade Creditors | 25,840 | 14,586 | 16,190 | 17,060 | 39,003 | 25,108 | 28,630 | 64,234 | 35,139 | 82,492 |
Group/Directors Accounts | 522 | 8,410 | ||||||||
other short term finances | ||||||||||
hp & lease commitments | ||||||||||
other current liabilities | ||||||||||
total current liabilities | 25,840 | 14,586 | 16,190 | 17,060 | 39,003 | 25,630 | 37,040 | 64,234 | 35,139 | 82,492 |
loans | ||||||||||
hp & lease commitments | ||||||||||
Accruals and Deferred Income | 799 | 773 | 817 | |||||||
other liabilities | 855 | 711 | ||||||||
provisions | 161 | 46 | 165 | 254 | 204 | |||||
total long term liabilities | 799 | 773 | 817 | 855 | 711 | 161 | 46 | 165 | 254 | 204 |
total liabilities | 26,639 | 15,359 | 17,007 | 17,915 | 39,714 | 25,791 | 37,086 | 64,399 | 35,393 | 82,696 |
net assets | 128,070 | 55,282 | 59,092 | 58,251 | 45,228 | 27,622 | 16,693 | 16,734 | 82,136 | 41,872 |
total shareholders funds | 128,070 | 55,282 | 59,092 | 58,251 | 45,228 | 27,622 | 16,693 | 16,734 | 82,136 | 41,872 |
Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||
Operating Profit | ||||||||||
Depreciation | 668 | 622 | 1,132 | 887 | 508 | |||||
Amortisation | ||||||||||
Tax | ||||||||||
Stock | ||||||||||
Debtors | 83,213 | -5,061 | -862 | -8,355 | 71,996 | -1,166 | -19,352 | 19,361 | -2,257 | 15,939 |
Creditors | 11,254 | -1,604 | -870 | -21,943 | 13,895 | -3,522 | -35,604 | 29,095 | -47,353 | 82,492 |
Accruals and Deferred Income | 26 | -44 | 817 | |||||||
Deferred Taxes & Provisions | -161 | 115 | -119 | -89 | 50 | 204 | ||||
Cash flow from operations | ||||||||||
Investing Activities | ||||||||||
capital expenditure | ||||||||||
Change in Investments | ||||||||||
cash flow from investments | ||||||||||
Financing Activities | ||||||||||
Bank loans | ||||||||||
Group/Directors Accounts | -522 | -7,888 | 8,410 | |||||||
Other Short Term Loans | ||||||||||
Long term loans | ||||||||||
Hire Purchase and Lease Commitments | ||||||||||
other long term liabilities | -855 | 144 | 711 | |||||||
share issue | ||||||||||
interest | ||||||||||
cash flow from financing | ||||||||||
cash and cash equivalents | ||||||||||
cash | -40,042 | 198 | -7,380 | -55,355 | -5,032 | 107,611 | ||||
overdraft | ||||||||||
change in cash | -40,042 | 198 | -7,380 | -55,355 | -5,032 | 107,611 |
Perform a competitor analysis for sympa medical ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in KY8 area or any other competitors across 12 key performance metrics.
SYMPA MEDICAL LTD group structure
Sympa Medical Ltd has no subsidiary companies.
Ultimate parent company
SYMPA MEDICAL LTD
SC468250
Sympa Medical Ltd currently has 2 directors. The longest serving directors include Mrs Shirley Beveridge (Jan 2014) and Mr Andrew Beveridge (Jan 2014).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Shirley Beveridge | United Kingdom | 62 years | Jan 2014 | - | Director |
Mr Andrew Beveridge | 63 years | Jan 2014 | - | Director |
P&L
January 2024turnover
275.1k
+106%
operating profit
97.1k
0%
gross margin
26.2%
+0.01%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2024net assets
128.1k
+1.32%
total assets
154.7k
+1.19%
cash
0
0%
net assets
Total assets minus all liabilities
company number
SC468250
Type
Private limited with Share Capital
industry
70229 - Management consultancy activities (other than financial management)
incorporation date
January 2014
age
11
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
January 2024
previous names
N/A
accountant
PATERSON BOYD & CO
auditor
-
address
8 mitchell street, leven, fife, KY8 4HJ
Bank
THE ROYAL BANK OF SCOTLAND PLC
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to sympa medical ltd.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SYMPA MEDICAL LTD. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|